12月9日 的 Luscii 應用程式分析
Luscii
- Luscii healthtech B.V.
- Apple App Store
- 免費版
- 醫療
Luscii is designed with patients in mind, offering an intuitive platform that makes remote care accessible and easy to use. By connecting patients with their healthcare providers, the app fosters a seamless experience for managing health conditions and treatments remotely. Luscii empowers patients with tools to monitor their health and stay informed while maintaining a close connection to their care team.
Video calling and secure chat features ensure you can reach your provider for advice, follow-ups, or check-ins when needed. Notifications keep you updated about essential actions or new information, while progress tracking helps you monitor key health metrics such as heart rate, blood pressure, weight, and pain levels in a single app.
With over a decade of experience and more than 350 implementations across 150 care pathways, Luscii is a trusted solution for remote care. Its effectiveness is validated by over 30 clinical studies, showing significant improvements in patient outcomes and overall care quality. Hundreds of healthcare institutions worldwide rely on Luscii to support diverse treatments and conditions, giving patients confidence in its capabilities.
Luscii is a CE-marked medical device that adheres to European safety and performance standards. Your data is processed in compliance with the
General Data Protection Regulation (GDPR), ensuring your privacy and security. Certified medical hardware compatible with Luscii meets rigorous standards for health, safety, and environmental protection in the European Economic Area. Luscii, based in Amsterdam, remains committed to patient safety and quality care.
It is important to note that Luscii is an enhancement to your medical treatment but does not replace it. Always consult your healthcare provider for personalized medical advice.
商店排名
商店排名基於Google和Apple設定的多個參數。
所有類別 在
美國--
醫療 在
美國--
建立帳戶即可查看平均每月下載次數聯絡我們
隨時間變化的 Luscii 排名統計
Similarweb 的使用排名和Apple App StoreLuscii排名
排名
無可用數據
12月 9, 2025